A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).

计划入组 29 人 · 首次发布于 2009 年 9 月 17 日

A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK

计划入组 10 人 · 首次发布于 2024 年 4 月 18 日

Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants

计划入组 38 人 · 首次发布于 2022 年 7 月 21 日

11C-TAU-7

Total Parenteral Nutrition

TAU-2023

Alpha Tau Medical

Israel

Total Metals Corp

United States

Sigma Tau I.f.r S.p.a.

Alamar Biosciences Revolutionizes Alzheimer's Detection with Blood-Based Brain-Derived Tau Assays

Amylyx's AMX0035 Shows Promise in Alzheimer's Disease Biomarker Study

Annovis Bio's Buntanetap Halts Cognitive Decline in Parkinson's Patients, Shows Strongest Effect in Amyloid Co-Pathology Subgroup